Catherine Chen

Zhong Lun Law Firm - China

Position:

Partner

Address:

Shanghai

Tel:

+86 21 6061 3599

Email:

Web:

Rating:

Highly regarded

Women Leaders

Languages:

Chinese & English

Bar admissions:

China

Jurisdictions:

Practice areas:

Investment funds

Recent transactional highlights

Advised Curon Biopharmaceutical on its US$150 million Series A financing, led by 6 Dimensions, Temasek and Boyu
Advised IDG on the formation of semiconductor and AI merger fund (Yiwu Jinhong Fund). This fund has raised RMB10.8 billion and is still in the process of fundraising.
Advised client during the whole process of the formation of the Beijing Fund (the “Fund”) jointly established by Tishman Speyer and Shougang Fund. Matter value is about RMB1.8 billion
Advised Lilly Asia Ventures on the merger of its portpolios, Hangzhou Just Biotherapeutics and MabSpace Biosciences to create Transcenta Holding Ltd., a world-class biotherapeutics company.

Practice areas

Investment funds
Private equity

Sector specialisations

Financial services
Healthcare
Investment management
Pharma and life sciences

Bar admissions

PRC Admitted Lawyer

Association memberships

Secretary General, CEIBS Alumni PE Association Shanghai
Member, Shanghai Bar Association Fund Research Committee
Mediator, Shanghai Pudong Professional Mediation Center
Co-chair, Fund Asset Backed Securitization Committee of China Asset Backed Securitization Forum

Academic qualifications

LL.M. (East China Univ. of Political Science and Law)
LL.B. (East China Univ. of Political Science and Law)
EMBA (China Europe International Business School)

Related lawyers

Jason Liu

Partner

Zhong Lun Law Firm

Moxi Zhang

Zhong Lun Law Firm

Ping (Evan) ZHANG

Partner

Zhong Lun Law Firm

Xining Dai

Zhong Lun Law Firm

Anthony Zhao

Partner

Zhong Lun Law Firm

View all